Dr. José M. Muñoz-Félix attained a degree in Biotechnology (2009) and Historia (2009) from the University of Salamanca. He completed his doctoral thesis in the Department of Physiology and Pharmacology at the University of Salamanca (2009–2015). He worked as a postdoctoral researcher at Barts Cancer Institute (Queen Mary University of London, United Kingdom) from 2016 to the end of 2020, at which time he returned to the University of Salamanca as Assistant Professor. Since June 2022, he has been a hired doctor in the Department of Biochemistry and Molecular Biology. He dedicates himself to the investigation of non-angiogenic tumors and metastasis and design strategies to inhibit their growth.
Dr. José M. Muñoz-Félix attained a degree in Biotechnology (2009) and Historia (2009) from the University of Salamanca. He completed his doctoral thesis in the Department of Physiology and Pharmacology at the University of Salamanca (2009–2015). He worked as a postdoctoral researcher at Barts Cancer Institute (Queen Mary University of London, United Kingdom) from 2016 to the end of 2020, at which time he returned to the University of Salamanca as Assistant Professor. Since June 2022, he has been a hired doctor in the Department of Biochemistry and Molecular Biology. He dedicates himself to the investigation of non-angiogenic tumors and metastasis and design strategies to inhibit their growth.